Vienna - Delayed Quote EUR

Pharma Mar, S.A. (PHM.VI)

Compare
88.60
+2.55
+(2.96%)
At close: 3:30:34 PM GMT+1

Research Analysis

Revenue vs. Earnings

Revenue 45.66M
Earnings 3.9M
Q4'23
Q1'24
Q2'24
Q3'24
0
10M
20M
30M
40M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in EUR Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 2255
Avg. Estimate 39.65M38.6M166.46M202.66M
Low Estimate 35.8M34.5M152M142.5M
High Estimate 43.5M42.7M179M288M
Year Ago Sales 40.51M37.97M158.15M166.46M
Sales Growth (year/est) -2.12%1.67%5.25%21.75%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
PHM.VI --------
S&P 500 9.91%10.33%14.01%13.75%

Related Tickers